China NMPA Product Recall - Single-photon emission computed tomography (SPECT) system, single-photon emission and X-ray computed tomography imaging system (models: Bright View, Brightview X, Brightview XCT)
China NMPA product recall for Single-photon emission computed tomography (SPECT) system, single-photon emission and X-ray computed tomography imaging system (models: Bright View, Brightview X, Brightview XCT) by Philips Medical Systems published April 06, 2017. Recall level: Level II. Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall for its Single-Photon Emi
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Single-photon emission computed tomography (SPECT) system, single-photon emission and X-ray computed tomography imaging system (models: Bright View, Brightview X, Brightview XCT) by Philips Medical Systems published April 06, 2017. Recall level: Level II. Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall for its Single-Photon Emi
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Philips Medical SystemsInspection Date
Unknown Date
Product Type
ID: d6f495f6-0fd8-4d57-a66e-8ce25d159ff1
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox